Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). Targets of Dasatinib are BCRABL, SRC, Ephrins and GFR.
| S.No | Brand Name | Strength Available | Manufacturer |
|---|---|---|---|
| 1 | DASATRUE TAB | 50MG, 70MG | CIPLA LTD |
| 2 | DASLEMIA TAB | 50MG, 70MG | INTAS PHARMACUTICALS |
| 3. | INVISTA TAB | 50MG, 70MG, 100MG | Dr.Reddy's |
| 4. | BEEDAN TAB | 20MG, 50MG, 70MG | ADLEY FORMULATIONS |
| 5. | SPRYCEL | 100MG | BRISTOL MYERS SQUIBB |